vTv Therapeutics Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $0 | $1.0M | $0 | $2.0M | $4.0M |
| Operating income | -$32.8M | -$24.2M | -$25.5M | -$22.5M | -$21.7M |
| Operating expenses | $32.8M | $25.2M | $25.5M | $24.6M | $25.7M |
| Cash from operations | -$25.3M | -$25.3M | -$19.1M | -$16.0M | -$19.3M |
| Capital expenditure | — | $0 | $0 | $21,000 | $0 |
| Free cash flow | — | -$25.3M | -$19.1M | -$16.0M | -$19.3M |
| Impairments | $0 | $0 | $0 | $0 | $0 |
| Total assets | $89.9M | $38.3M | $11.0M | $33.2M | $25.5M |
| Total liabilities | $25.5M | $24.0M | $29.6M | $27.4M | $10.3M |
Shares outstanding 3.9M · Free float 88.4%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.